Reshetnik Alexander, Gohlisch Christopher, Abou-Dakn Michael, Tölle Markus, Zidek Walter, van der Giet Markus
Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Campus Benjamin Franklin, Department of Nephrology.
Department of Gynecology and Obstetrics, St Joseph's Hospital Berlin Tempelhof, Berlin, Germany.
Blood Press Monit. 2019 Apr;24(2):99-101. doi: 10.1097/MBP.0000000000000370.
To validate noninvasive oscillometric blood pressure (NIBP) 2020 up pressure (UP) upper arm blood pressure (BP) monitoring technology according to the European Society of Hypertension International Protocol revision 2010 (ESH-IP revision 2010). According to the protocol, 33 participants were included. NIBP2020 UP technology was integrated into the BP+ host device, and common upper arm cuffs were used. The study included patients from ambulatory Hypertension Units. The validation procedure was performed exactly as required by ESH-IP revision 2010. Overall, 57.6% of the study population was female. Mean age was 45.5±16.3 years. Mean systolic blood pressure (SBP) was 142.9±30.6 mmHg and mean diastolic blood pressure (DBP) was 89.0±24.9 mmHg. The number of measurements within the difference range of up to 5 mmHg was 86 for SBP and 92 for DBP; 95 measurements of SBP and 99 of DBP were within the difference range of up to 10 mmHg, and 97 measurements of SBP and 99 measurement of DBP were in the difference range of up to 15 mmHg. Mean observer-test device differences were -0.2±4.6 mmHg for SBP and 0.6±3.1 mmHg for DBP. At least two observer-test differences were up to 5 mmHg for SBP in all participants and for DBP in 31 participants. All participants had at least one measurement with an observer-test difference of up to 5 mmHg for SBP and DBP. The NIBP2020 UP technology integrated into the BP+ host device using common upper arm cuffs passed the validation criteria according to the ESH-IP revision 2010.
根据欧洲高血压学会2010年国际协议修订版（ESH-IP修订版2010），验证无创示波血压（NIBP）2020上压（UP）上臂血压（BP）监测技术。根据该协议，纳入了33名参与者。NIBP2020 UP技术被集成到BP+主机设备中，并使用了普通的上臂袖带。该研究纳入了来自门诊高血压科室的患者。验证程序严格按照ESH-IP修订版2010的要求进行。总体而言，研究人群中57.6%为女性。平均年龄为45.5±16.3岁。平均收缩压（SBP）为142.9±30.6 mmHg，平均舒张压（DBP）为89.0±24.9 mmHg。收缩压在相差高达5 mmHg范围内的测量次数为86次，舒张压为92次；收缩压95次测量和舒张压99次测量在相差高达10 mmHg范围内，收缩压97次测量和舒张压99次测量在相差高达15 mmHg范围内。观察者与测试设备的平均差异为：收缩压-0.2±4.6 mmHg，舒张压0.6±3.1 mmHg。在所有参与者中，收缩压至少有两次观察者与测试设备差异高达5 mmHg，31名参与者的舒张压也是如此。所有参与者的收缩压和舒张压至少有一次测量的观察者与测试设备差异高达5 mmHg。集成到BP+主机设备中并使用普通上臂袖带的NIBP2020 UP技术通过了ESH-IP修订版2010的验证标准。
